UNIVERSITY OPHTHALMOLOGY CONSULTANTS
 

CASE OF THE MONTH

CASE #9

 
PLASMINOGEN ACTIVATOR ABNORMALITIES

Both Kazama et al. and Soria et al. (cited in 1) have reported plasminogen deficiency and dysplasminogenemia with thrombotic disorders. Similarly, abnormalities in plasminogen activator have been associated with retinal venous occlusion. The release of t-PA from the endothelium initiates intravascular fibrinolysis, which is also regulated by its inhibitor, plasminogen activator inhibitor-I.

1. Baghat N, Goldberg MF, Gascon P, Bell W, Haberman J, Zarbin MA. Central retinal vein occlusion: review of management. Eur J Ophthalmol 1999; 9: 165-80.

 

Back to previous page

 

umdnj web site directions staff directory home page